Anxiety and Hashimoto Disease: When It Is the Thyroid, When It Is Not

Anxiety is common in Hashimoto disease — both as a direct neuropsychiatric effect and as a comorbid condition. TSH variability and levothyroxine over-replacement can mimic or trigger anxiety. Persistent anxiety at stable, normal TSH should be evaluated for a primary anxiety disorder.

Why Hashimoto disease can produce anxiety symptoms

Thyroid hormone is not a peripheral signal that happens to influence the brain — it is a central regulator of brain metabolism, neurotransmitter turnover, and synaptic activity. The T3 receptor is expressed throughout the limbic system (amygdala, hippocampus, prefrontal cortex), and small shifts in T3 availability change how those circuits respond to stress and threat [C2][C7].

In Hashimoto disease, three mechanisms plausibly link the autoimmune process to anxiety symptoms [C1][C2][C5]:

• TPO antibody activity. Anti-TPO antibodies are associated with anxiety and depression even at normal TSH in some cohorts, suggesting a direct neuropsychiatric signal of the autoimmune process — not only a consequence of hormone deficiency [C1][C5].
• Hormone variability. During the early phase of Hashimoto disease the gland can oscillate between hashitoxicosis (transient hyperthyroid) and hypothyroid states, producing days of palpitations, insomnia, and jitteriness that look identical to panic [C6].
• Limbic and mitochondrial signalling. T3 modulates mitochondrial function in neurons; preclinical work links altered thyroid signalling to panic-circuit sensitivity, though direct human evidence is limited [C2][C7].

The 2018 Siegmann meta-analysis is the cleanest summary: across studies, autoimmune thyroiditis was associated with significantly higher odds of both anxiety and depressive disorders compared with euthyroid controls [C1].

The clinical pattern in practice

Anxiety in Hashimoto disease typically shows up in one of three patterns [C1][C5][C6]:

1. Hashitoxicosis phase. Early in the disease, autoimmune destruction releases stored hormone in pulses. Patients describe sudden palpitations, tremor, insomnia, and a sense of dread — episodes lasting hours to days, often before diagnosis [C6].
2. Untreated or undertreated hypothyroidism. Slower, more diffuse anxiety mixed with low mood, fatigue, and cognitive slowing. TSH is elevated and free T4 may be low [C1][C8].
3. Over-replacement on levothyroxine. A jittery, "wired-but-tired" feeling with palpitations at rest, sleep-onset insomnia, and heat intolerance. TSH is suppressed (often below 0.1 mIU/L) [C3][C4].

The 2026 Baskaran systematic review confirms that neuropsychiatric adverse events — including anxiety, palpitations and insomnia — are the most consistently reported class of levothyroxine side effects, almost always linked to over-replacement rather than the drug itself [C4].

What recovers on adequate levothyroxine

For patients whose anxiety is driven by thyroid dysfunction itself, the timeline tracks TSH normalization [C3][C8]:

• Weeks 2–6: palpitations, jitteriness and sleep-onset insomnia from hashitoxicosis or over-replacement fade as hormone levels stabilize.
• Weeks 6–12: baseline anxiety from frank hypothyroidism (the slower, low-mood pattern) typically softens as TSH falls into range and brain T3 availability rises [C1][C2].
• Months 3–6: most thyroid-attributable mood and anxiety symptoms have either resolved or clearly improved if dosing is correct [C3].

Patients should know upfront that anxiety driven by the thyroid responds to the dose, not to additional supplements [C3][C8].

When anxiety persists at a normal TSH

If TSH has been in the lab's reference range (often 0.5–2.5 mIU/L symptomatically) for at least 8–12 weeks and anxiety has not improved, the next step is usually not another dose change [C3][C8]. Persistent anxiety at a stable, normal TSH points to several scenarios [C1][C2][C7]:

1. Primary anxiety disorder. Generalized anxiety, panic disorder and social anxiety are common in the general population and more common in Hashimoto patients than in controls [C1]. They warrant a standard psychiatric workup, not endless thyroid retesting.
2. Comorbid depression. Depression and anxiety overlap heavily in Hashimoto cohorts; one often masks the other [C1].
3. Subclinical over-replacement. TSH at the very low end of normal (e.g., 0.3 mIU/L) can still produce jittery symptoms in sensitive patients. A small dose reduction with TSH recheck at 6–8 weeks is reasonable if the clinician suspects this [C3][C4].
4. Stress, sleep, caffeine and alcohol. All can drive anxiety regardless of thyroid status; addressing them often helps more than further endocrine workup [C8].
5. Other endocrine causes — pheochromocytoma, perimenopause, postpartum shifts — are rarer but worth considering when the clinical picture does not fit [C6].

The 2026 Al Qaderi review summarizes the practical principle: thyroid testing is a reasonable first step in new-onset anxiety, but persistent anxiety at normal TSH should be referred to mental health, not pursued with progressively narrower thyroid tweaks [C2].

What does NOT help

Several heavily-marketed approaches lack evidence for thyroid-related anxiety [C2][C3][C4]:

• Ashwagandha. Marketed as an "anxiety and thyroid" adaptogen, ashwagandha has documented thyrotoxicosis case reports and can destabilize Hashimoto patients. The anxiolytic data are weak and mostly come from healthy volunteers, not autoimmune cohorts [C4]. See our ashwagandha-thyroid article.
• Adding T3 (liothyronine) to improve mood. The ATA does not recommend routine T3 addition for residual symptoms, and adding T3 frequently produces the same jittery, palpitation-driven anxiety as over-replacement [C3].
• Pushing TSH below 0.5 mIU/L to "feel better." Patients sometimes request a higher dose to chase residual symptoms. Suppressed TSH increases the risk of atrial fibrillation, bone loss and the anxiety-mimicking adverse events documented by Baskaran 2026 [C3][C4].
• High-dose iodine, kelp, or "thyroid support" blends. These can trigger flares in Hashimoto disease and worsen symptom volatility [C8].
• Stimulant nootropics and high caffeine intake while dosing is unstable. They amplify palpitations and insomnia and confound the clinical picture [C4].

Practical guidelines

1. Get a full thyroid panel (TSH, free T4, TPO antibodies) at the start of any new anxiety workup. Repeat TSH after any dose change in 6–8 weeks [C3][C8].
2. Stabilize TSH first. Most thyroid-driven anxiety resolves once TSH is stable in the reference range; pushing past that point rarely helps and often hurts [C3].
3. Track symptoms against TSH. If anxiety lifts when TSH normalizes, the thyroid was driving it. If anxiety persists at normal TSH for 8–12 weeks, redirect the workup [C2].
4. Treat over-replacement seriously. A suppressed TSH plus palpitations and insomnia warrants a dose reduction, not symptom management [C3][C4].
5. Refer to mental health when appropriate. Persistent anxiety at normal TSH is a treatable primary disorder; standard psychotherapy and, when indicated, SSRIs work as well in Hashimoto patients as in others [C1][C2].
6. Limit caffeine and alcohol during dose adjustments. Both amplify the cardiac and sleep symptoms that look like anxiety [C4].

Frequently asked questions

Is anxiety really a Hashimoto symptom? Yes. Multiple studies and the 2018 Siegmann meta-analysis show higher rates of anxiety and depression in autoimmune thyroiditis compared with controls — independent of overt hormone deficiency in some cohorts [C1][C5].

Can levothyroxine cause anxiety? At correct doses, no. Over-replacement (suppressed TSH) produces palpitations, insomnia and a jittery feeling that closely mimics anxiety. The fix is dose reduction, not a sedative [C3][C4].

My TSH is normal but I still feel anxious. What now? After at least 8–12 weeks of a stable, normal TSH, persistent anxiety should be evaluated as a primary anxiety disorder rather than re-adjusting thyroid hormone [C2][C3].

Will ashwagandha help my Hashimoto anxiety? There is no convincing evidence for ashwagandha in thyroid-related anxiety, and it has documented thyrotoxicosis risk in Hashimoto patients. The ATA does not endorse it [C4][C8].

Should I add T3 if I still have anxiety on levothyroxine? Adding T3 frequently produces over-replacement symptoms — palpitations, insomnia, jitteriness — and is not recommended as a first-line solution for residual anxiety by the ATA [C3].

Bottom line

Anxiety in Hashimoto disease is real and biologically grounded: the autoimmune process, TSH variability, and over-replacement can each generate symptoms that look like a primary anxiety disorder [C1][C2][C5]. Most thyroid-driven anxiety improves within 3 to 6 months once TSH is stable and in range [C3][C8]. Persistent anxiety at a stable normal TSH is best evaluated as a primary anxiety disorder, not chased with more dose changes [C2]. Ashwagandha, added T3, and TSH suppression are not evidence-based fixes and can make things worse [C3][C4].

Sources

1. [C1] Siegmann EM et al. Association of Depression and Anxiety Disorders With Autoimmune Thyroiditis: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2018. PubMed: 29800939
2. [C2] Al Qaderi AH et al. Exploring the Connection Between Thyroid Health and Psychiatric Disorders: A Comprehensive Review With a Focus on Schizophrenia and Bipolar Disorder. 2026. PubMed: 41732642
3. [C3] Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670–1751. PubMed: 25266247
4. [C4] Baskaran BS et al. Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review. 2026. PubMed: 41559017
5. [C5] Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391–397. PubMed: 24434360
6. [C6] Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646–2655. PubMed: 12826640
7. [C7] Gordon ML. The Influence of Reverse Triiodothyronine on Neuropsychiatric Disorders: A Narrative Review. 2026. PubMed: 41168656
8. [C8] American Thyroid Association. Hypothyroidism — Patient Information. thyroid.org

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.